BioInvest 2005, the Biotechnology and Life Sciences Informatics Investment Meeting Selects 8 Companies to Present in London

    *** Delegates from the financial sector should contact Jon Rees on 01865 484224 to request a complimentary pass ***

The BioInvest 2005 conference is a joint initiative of the UK Bioinformatics Forum and Oxfordshire Bioscience Network and Oxford Science Enterprise Centre, Said Business School with support from UKTI, and Northbank Communications as the communications partner. Includes refreshments, lunch and wine reception.

Networking drinks reception from 16.30 - 19.00 at the conference venue.

Attendees will include seed fund managers, angel investors, venture capitalists, private equity managers and biotech/pharmaceutical executives, all looking for investment opportunities within the biotech and bioinformatics industries.

BioInvest 2005 allows investors to meet with leading and emerging biotechnology and informatics companies. Companies presenting include:

Robert Feldman, CEO, Riotech Pharma
David Laskow Pooley, CEO, Surface Therapeutics
Yasmin Crawford, Director, Opal Healthcare Limited
Dr Dan Daly, Director, Lein Diagnostics
Christian Rohlff, CEO, Oxford Genome Sciences
Andrew Payne, CEO, Intellidos
Mark Tucker, CEO, G-Nostics
Will Saurin, CEO, Genomining

Company appraisals are available on the web www.bioinvest2005.com

Dr Jon Rees
UK Bioinformatics Forum
Email [email protected]
Tel. 01865 484224
Fax. 01865 484478
http://www.bioinformaticsforumuk.net

*** Delegates from the financial sector should contact Jon Rees on 01865 484224 to request a complimentary pass ***

Dr Jon Rees (Project Manager)
UK Bioinformatics Forum
Tel. 01865 484224
Fax. 01865 484478
http://www.bioinformaticsforumuk.net

# # #